MoneyWorks4Me

Neuland Laboratories - Quaterly Results

10 May 2022 Evaluate
With no major difference for the quarter endedMarch 2022 , the total revenue stood at Rs. 2558.73  millions.Net Profit recorded in the quarter ended March 2022 rise to 26.69% to Rs. 218.27  millions  compared to R. 172.28 millions in corresponding previous quarter.A decline of 393.44 millions was observed in the OP in the quarter ended March 2022 from 400.35 millions on QoQ basis.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 2558.73 2447.05 4.56 9510.77 9369.13 1.51 9510.77 9369.13 1.51
Other Income 6.31 145.96 -95.68 20.77 160.95 -87.10 20.77 160.95 -87.10
PBIDT 393.44 400.35 -1.73 1442.70 1625.38 -11.24 1442.70 1625.38 -11.24
Interest 27.70 45.78 -39.49 134.94 178.98 -24.61 134.94 178.98 -24.61
PBDT 365.74 354.57 3.15 1307.76 1446.40 -9.59 1307.76 1446.40 -9.59
Depreciation 124.52 111.41 11.77 490.36 396.78 23.58 490.36 396.78 23.58
PBT 241.22 243.16 -0.80 817.40 1049.62 -22.12 817.40 1049.62 -22.12
TAX 22.95 70.88 -67.62 182.06 246.67 -26.19 182.06 246.67 -26.19
Deferred Tax -47.35 23.87 -298.37 -22.16 121.84 -118.19 -22.16 121.84 -118.19
PAT 218.27 172.28 26.69 635.34 802.95 -20.87 635.34 802.95 -20.87
Equity 129.00 129.00 0.00 129.00 129.00 0.00 129.00 129.00 0.00
PBIDTM(%) 15.38 16.36 -6.02 15.17 17.35 -12.56 15.17 17.35 -12.56
Peers
Company Name CMP
Sun Pharma. Inds. 1853.50
Dr. Reddys Labs. 1202.80
Cipla 1397.20
Lupin 2090.00
Zydus Lifesciences 1202.00
View more..